Biography and Research Information
OverviewAI-generated summary
Edita M. Newton's research has focused on dermatologic conditions and the adverse effects of cancer therapies. Newton has investigated the aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signaling pathway as a potential therapeutic target for atopic dermatitis. Additionally, Newton has documented the adverse dermatologic effects of erdafitinib, an antineoplastic agent, in a patient with metastatic urothelial carcinoma. Other research interests include graft-versus-host disease-like erythroderma as a paraneoplastic disorder, infantile hemangiomas, and nail diseases.
Metrics
- h-index: 1
- Publications: 1
- Citations: 35
Positions
-
Resident Physician 2018–presentUniversity of Arkansas for Medical Sciences Dermatology ORCID
Selected Publications
-
Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis (2022)
Collaboration Network
Top Collaborators
- Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
- Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
- Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
Similar Researchers
Based on overlapping research topics